Status:
ENROLLING_BY_INVITATION
Establishment of Genetic Basis for Neurological Disease by Genetic Screening
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Neuro-Degenerative Disease
Eligibility:
All Genders
18-80 years
Brief Summary
Hereditary neurological disorders are relatively common in paediatric neurological practice, but it has considerable overlap with adult neurological disorders. It is a group of of genetic diseases, mo...
Detailed Description
The human iPS is generated by direct reprogramming of human somatic cells. These hiPS cells can give rise to most tissue types in the human embryo and possess many of the properties of human embryonic...
Eligibility Criteria
Inclusion
- Individuals at age 18 years or older who have presumed hereditary neurological disease.
- Individuals or his/her guardian who can provide the informed consent.
Exclusion
- Individuals who are allergic to local anesthetics.
- Individuals who have serious medical conditions that restrict their ability to tolerate skin biopsy.
- Individuals who have history of bleeding diathesis or use of anticoagulant medications. Patients taking nonsteroidal anti-inflammatory agents will be asked to discontinue these medications 3 days prior to skin biopsy.
Key Trial Info
Start Date :
November 16 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03322306
Start Date
November 16 2012
End Date
December 31 2025
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Shatin, Hong Kong, 000